Can the oncology classification system be used for prosthetic joint infection?: The PJI-TNM system.
Bone Joint Res
Charité - Universitätsmedizin Berlin, Berlin, Germany; Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Center for Musculoskeletal Surgery (CMSC), Berlin, Germany.
Published: February 2020
2020;9(2):79-81.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7229309 | PMC |
| http://dx.doi.org/10.1302/2046-3758.92.BJR-2019-0134.R1 | DOI Listing |
Similar Publications
Postoperative nutritional support after pancreaticoduodenectomy in adults.
Cochrane Database Syst Rev
March 2025
Surgical and Translational Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Auckland, New Zealand.
Background: Resection of the head of the pancreas is most commonly done by a pancreaticoduodenectomy, known as a Whipple procedure. The most common indication for pancreaticoduodenectomy is malignancy, but can include benign tumours and chronic pancreatitis. Complete surgical resection, with negative margins, provides the best prospect of long-term survival.
View Article and Find Full Text PDFKey prognostic factors in transarterial chemoembolization combined with sorafenib treatment for hepatocellular carcinoma with portal vein tumor thrombosis.
Am J Cancer Res
February 2025
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University Chongqing 400016, China.
Background: Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide, with portal vein tumor thrombosis (PVTT) worsening its prognosis and complicating management. The combination of transarterial chemoembolization (TACE) and the targeted agent sorafenib has been proposed to improve treatment outcomes. This study investigates the prognostic factors influencing the effectiveness of this combined treatment in HCC patients with PVTT.
View Article and Find Full Text PDFPredictive nomogram for risk of pulmonary infection in lung cancer patients undergoing radiochemotherapy: development and performance evaluation.
Am J Cancer Res
February 2025
Department of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan 430079, Hubei, China.
Objective: To develop an accurate predictive model for identifying patients at high risk of pulmonary infection during radiochemotherapy.
Methods: We retrospectively analyzed data from 544 lung cancer patients treated at Hubei Cancer Hospital between May 2019 and October 2022. The patients were divided into training and validation groups (7:3 ratio).
Basic and applied research progress of TRAIL in hematologic malignancies.
Blood Sci
June 2025
Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hematological malignancies encompass a diverse range of blood-related cancers characterized by abnormal blood cell production. These cancers, classified by the World Health Organization based on lineage, cell origin, and progression, provide a more comprehensive framework for understanding cancer biology. This classification has significantly advanced cancer research, particularly in genetic analyses for diagnosis and treatment.
View Article and Find Full Text PDFDetection of radiosensitive subpopulations with Raman microspectroscopy.
Front Oncol
February 2025
School of Physics, Clinical and Optometric Sciences, Technological University Dublin, Dublin, Ireland.
Although significant advances in understanding the molecular drivers of acquired and inherited radiosensitivity have occurred in recent decades, a single analytical method which can detect and classify radiosensitivity remains elusive. Raman microspectroscopy has demonstrated capabilities in the objective classification of various diseases, and more recently in the detection and modelling of radiobiological effect. In this study, Raman spectroscopy is presented as a potential tool for the detection of radiosensitivity subpopulations represented by four lymphoblastoid cell lines derived from individuals with ataxia telangiectasia (2 lines), non-Hodgkins lymphoma, and Turner's syndrome.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!
© LitMetric 2025. All rights reserved.